Skip to content

High Versus Normal Protein Diet in Polycystic Ovary Syndrome (PCOS)

Effect of High-protein or Normal-protein Diet on Weight Loss, Body Composition, Hormone and Metabolic Profile in Women With Polycystic Ovary Syndrome From South Brazil: A Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01184963
Enrollment
40
Registered
2010-08-19
Start date
2008-03-31
Completion date
2009-12-31
Last updated
2010-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

PCOS, High protein diet

Brief summary

The objective of this study is to assess the effects of a high protein (HP) and a normal protein diet (NP) on patients with polycystic ovary syndrome (PCOS) and body mass index (BMI)-matched controls in a sample of southern Brazilian women. Patients will be randomized to receive high protein (30% protein, 40% carbohydrate, 30% lipid) or normal protein (15% protein, 55% carbohydrate, 30% lipid) during eight weeks. The investigators hypothesis is that a different diet composition may have influences in changes of the main characteristics of PCOS, like hyperandrogenism and metabolic syndrome.

Interventions

DIETARY_SUPPLEMENTHigh protein diet

High protein diet (30% protein, 40% carbohydrate, 30% lipid)

DIETARY_SUPPLEMENTNormal protein diet

Normal protein diet (15% protein, 55% carbohydrate, 30% lipid

Sponsors

Hospital de Clinicas de Porto Alegre
CollaboratorOTHER
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Federal University of Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* women of reproductive age * BMI ranging from 18.5 to 39.9 kg/m²

Exclusion criteria

* Use of any drugs known to interfere with hormone levels for at least 3 months before the study * Women with known type 2 diabetes, liver or renal disease or thyroid dysfunction * Other hyperandrogenic disorders than PCOS

Design outcomes

Primary

MeasureTime frame
Changes in corporal weight8 weeks

Secondary

MeasureTime frame
Changes in body composition8 weeks
changes in hormone and metabolic profile.8 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026